TXMD

Q: What is the price of TherapeuticsMD (TXMD) today?

The price of TherapeuticsMD (TXMD) today is $ 2.17, with return of 199.23% compared to the last year. The price of TherapeuticsMD (TXMD) started the year trading around $ 1.63 and today it is at $ 2.17. Follow the real-time price chart, the historical price of TherapeuticsMD (TXMD) and international markets.

Q: When does TherapeuticsMD (TXMD) pay dividends?

TherapeuticsMD (TXMD) did not distribute dividends in the last year.

Q: Is TherapeuticsMD (TXMD) worth it?

Currently, TherapeuticsMD (TXMD) is priced at $ 2.17, with a P/E of 86.80%, representing a deviation of 1,954% from its historical average P/E. In the last year, the stock showed a variation of 199.23 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 199.23%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy TherapeuticsMD (TXMD) stock?

Investing in stocks of TherapeuticsMD (TXMD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of TherapeuticsMD (TXMD) yield today?

The yield of TherapeuticsMD (TXMD) was -8.05% in the last month, 199.23% in the last year and -97.29% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of TherapeuticsMD (TXMD) today, the total investment would be $ 217.00, based on the current price of $ 2.17.If past performance were to repeat, the return on your investment would be:In 1 year: $ 649.33In 5 years: $ 5.88In 10 years: $ 1.54It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

TherapeuticsMD Inc.

Price

$ 2.17

return (12m)

199.23%

p/e

86.80

p/bv

0.95

DIVIDEND YIELD

0.00%

TXMD price

TXMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment TXMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.05%

3 months

27.65%

1 year

199.23%

2 years

-9.58%

5 years

-97.29%

10 years

-99.29%

Fundamentals TXMD

review the fundamentals of TherapeuticsMD shares

P/E

86.80

Sector: -2.05 Industry: 7.13

P/S (PSR)

9.33

Sector: 1.91 Industry: 1.67

P/BV

0.95

Sector: 2.15 Industry: 2.99

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: 0.01%

ROA

0.78%

Sector: -26.68% Industry: 2.20%

ROE

1.09%

Sector: -30.10% Industry: 3.45%

ROIC

-10.76%

Sector: -419.47% Industry: -3.73%

NET MARGIN

10.75%

Sector: -28.71% Industry: 1.11%

GROSS MARGIN

100.00%

Sector: 44.63% Industry: 25.61%

OPERATING MARGIN

-93.55%

Sector: -24.00% Industry: 0.74%

EV/EBITDA

-34.72

Sector: -0.49 Industry: 3.28

EV/EBIT

-22.84

Sector: -2.22 Industry: 1.76

PRICE-TO-ASSETS

0.67

Sector: 1.16 Industry: 1.42

BVPS

2.29

Sector: 3.53 Industry: 11.92

EPS

0.03

Sector: -0.92 Industry: 1.04

EQUITY-TO-ASSETS RATIO

0.71

Sector: 0.43 Industry: 0.46

LIABILITIES / ASSETS

0.29

Sector: 0.47 Industry: 0.52

CAGR REVENUE 5 YEARS

-49.73%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF TherapeuticsMD ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 2.17

Fair Value

$ 0.00

Upside/Downside Return potential.

-42.71%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals TXMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	42.72	36.97	86.53%	0.63%	$ 881.65 B	31.66%
ISRG	58.69	9.34	15.92%	0.00%	$ 167.62 B	28.38%
TMO	26.04	3.26	12.52%	0.37%	$ 174.60 B	15.05%
SNY	11.67	1.27	10.86%	5.07%	$ 106.43 B	18.68%
NVS	21.01	6.31	30.04%	4.54%	$ 293.84 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	24.24	2.27	9.38%	3.25%	$ 111.80 B	13.00%
CVS	54.69	1.28	2.35%	3.49%	$ 96.69 B	0.44%
GSK	14.07	5.02	35.71%	3.12%	$ 107.31 B	17.48%
BSX	35.38	0.00	0.00%	0.00%	$ 102.52 B	14.44%
TMDX	22.06	8.87	40.22%	0.00%	$ 4.20 B	31.43%
HCA	17.91	-43.85	-244.82%	0.54%	$ 121.52 B	8.97%
IDXX	43.33	28.59	65.99%	0.00%	$ 45.91 B	24.62%
RMD	22.68	5.33	23.51%	1.24%	$ 33.70 B	27.53%
DHR	36.65	2.52	6.88%	0.68%	$ 132.44 B	14.71%
INMD	9.09	1.25	13.73%	0.00%	$ 853.02 M	25.32%
PHG	25.47	2.05	8.06%	3.19%	$ 26.43 B	5.07%
FMS	11.55	0.78	6.75%	3.45%	$ 13.04 B	5.02%
SYK	39.63	5.74	14.48%	1.01%	$ 128.65 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

TXMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	06/10/2008	06/10/2008	666,66666600

ABOUT TherapeuticsMD

TherapeuticsMD Inc.

Average Investor10 user rating

4.0 (0 people)

United States

119 years

Founded: 1907

2007

Time since IPO - 19 years

400

Employees

The Company TherapeuticsMD Inc. (United States), is listed on Nasdaq with a market value of $ 26.04 Millions, having an equity of $ 27.44 Millions.

With a total of 400 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 2.79 Millions, which generated a profit in the amount of $ 300.00 Thousand.

As for its main indicators, the Company has a P/E ratio of 86.80, a P/BV ratio of 0.95 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker TXMD.

Market cap

$ 26.04 Millions

Net worth

$ 27.44 Millions

US$ 27,440,000.00

Assets

$ 38.67 Millions

US$ 38,670,000.00

Total Shares Outstanding

12.00 Millions

12,000,000

Average Daily Trading Volume

$ 88.99 Thousand

US$ 88,994.00

Sector

Health

Industry

Pharmaceutical Products

TXMD

TXMD revenue and profits

Financial Results TXMD

DRAG THE FRAME TO SEE MORE DATA

TXMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 76.13 20,33% (12M)

P/E

54.69

3.49%

ROE

2.35%

P/BV

1.28

CI - Cigna

$ 267.19 --12,37% (12M)

P/E

10.34

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 34.45 --40,80% (12M)

P/E

-2.54

0.00%

ROE

-33.28%

P/BV

0.85

HUM - Humana

$ 165.43 --33,34% (12M)

P/E

16.71

2.14%

ROE

6.70%

P/BV

1.12

HCA - HCA Healthcare

$ 532.97 68,39% (12M)

P/E

17.91

0.54%

ROE

-244.82%

P/BV

-43.85

LLY - Eli Lilly

$ 985.08 20,31% (12M)

P/E

42.72

0.63%

ROE

86.53%

P/BV

36.97

NVS - Novartis

$ 153.44 48,61% (12M)

P/E

21.01

4.54%

ROE

30.04%

P/BV

6.31